Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Uveitis and Ocular Immunology
What strategies do you use to manage refractory cystoid macular edema in uveitis patients who have already received ocular steroids and systemic immunosuppression?
Related Questions
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
When would you consider discontinuing immunosuppressive treatment in a quiescent uveitis patient without systemic manifestations of inflammation?
When would you consider using selective laser trabeculoplasty (SLT) for managing uveitic glaucoma?
How do you approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
For those using 5% Betadine as a single-use prep, how are you handling the associated costs or aliquoting?
What is your preferred regimen for treating recalcitrant and recurrent macula-threatening ocular toxoplasmosis?
When should you consider performing an AC tap in patients with suspected herpetic uveitis?
How do you manage Cancer-Associated Retinopathy (CAR) in a patient who doesn’t have a known cancer diagnosis, given the difficulty in finding the underlying cancer and the risks of using immunosuppressive treatments to preserve vision?
How do you differentiate between ocular involvement due to active tuberculosis versus latent infection in a patient with uveitis and suspected tuberculosis?
